Discover the full record of transactions filed by 徐洁, Vice-Présidente. Insider active across 1 company, notably 昭衍新药. In total, 44 filings have been published. History available since 30 September 2025. The latest transaction was disclosed on 30 September 2025 (Sale). Regulator: SSE / SZSE (CSRC). All data is free.
Declarations 44 total
● 董事,高级管理人员 · Executives · 30 Sept 2025 · 昭衍新药 20,000 shares A股 SSE:173000009615288770 ● 董事 · Executives · 13 Nov 2023 · 昭衍新药 4,000 shares A股 SSE:173000007087307460 ● 董事 · Executives · 8 Nov 2023 · 昭衍新药 3,000 shares A股 SSE:173000007075373760 ● 董事 · Executives · 6 Nov 2023 · 昭衍新药 199,960 shares A股 SSE:173000007068789150 ● 董事 · Executives · 3 Nov 2023 · 昭衍新药 148,000 shares A股 SSE:173000007065879970 ● 董事 · Executives · 3 Nov 2023 · 昭衍新药 489,940 shares A股 SSE:173000007065879800 ● 董事 · Executives · 2 Nov 2023 · 昭衍新药 1,000,000 shares A股 SSE:173000007060665860 ● 董事 · Executives · 27 Jun 2023 · 昭衍新药 300,000 shares A股 SSE:173000006685315140 ● 董事 · Executives · 26 Jun 2023 · 昭衍新药 200,000 shares A股 SSE:173000006682445340 ● 董事 · Executives · 16 Jun 2023 · 昭衍新药 300,000 shares A股 SSE:173000006666870560 ● 董事 · Executives · 12 Jun 2023 · 昭衍新药 196,300 shares A股 SSE:173000006654602560 ● 董事 · Executives · 27 Sept 2022 · 昭衍新药 3,025,954 shares A股 SSE:173000005913389900 ● 董事 · Executives · 6 Sept 2022 · 昭衍新药 2,141,980 shares A股 SSE:173000005894076400 ● 副总裁 · Executives · 4 Jul 2022 · 昭衍新药 10,584 shares A股 SSE:173000005746690560 ● 董事 · Executives · 1 Jul 2022 · 昭衍新药 2,000 shares A股 SSE:173000005648954080 ● 董事 · Executives · 23 Jun 2022 · 昭衍新药 4,775,000 shares A股 SSE:173000005614953250 ● 董事 · Executives · 16 Jun 2022 · 昭衍新药 1,000 shares A股 SSE:173000005599083140 ● 董事 · Executives · 7 Jun 2022 · 昭衍新药 1,000 shares A股 SSE:173000005576250560 ● 董事 · Executives · 26 May 2022 · 昭衍新药 320,000 shares A股 SSE:173000005552153250 ● 董事 · Executives · 24 May 2022 · 昭衍新药 460,400 shares A股 SSE:173000005547691360 ● 董事 · Executives · 23 May 2022 · 昭衍新药 456,370 shares A股 SSE:173000005545269540 ● 董事 · Executives · 20 May 2022 · 昭衍新药 286,160 shares A股 SSE:173000005542844740 ● 董事长 · Executives · 11 May 2022 · 昭衍新药 300,000 shares A股 SSE:173000005552088300 ● 董事 · Executives · 16 Dec 2021 · 昭衍新药 192,700 shares A股 SSE:173000005176769470 ● 董事 · Executives · 29 Sept 2021 · 昭衍新药 246,100 shares A股 SSE:173000004928451940 25 of 44 declarations
Load more (19 remaining) About 徐洁 Xu Jie is the Vice President at Zhaoyan New Drug. She is responsible for managing operations and strategic development of the company. Her role involves coordinating teams and optimizing processes.